Yin Shan Eric Ng
Overview
Explore the profile of Yin Shan Eric Ng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Z, Cano I, Lei F, Liu J, Ramos R, Gordon H, et al.
Circ Res
. 2024 Nov;
136(1):59-74.
PMID: 39584795
Background: EMCN (endomucin), an endothelial-specific glycocalyx component, was found to be highly expressed by the endothelium of the renal glomerulus. We reported an anti-inflammatory role of EMCN and its involvement...
2.
Hu Z, Cano I, Lei F, Liu J, Ramos R, Gordon H, et al.
bioRxiv
. 2024 Jul;
PMID: 39071302
Background: Endomucin (EMCN), an endothelial-specific glycocalyx component, was found to be highly expressed by the endothelium of the renal glomerulus. We reported an anti-inflammatory role of EMCN and its involvement...
3.
Cano I, Wild M, Gupta U, Chaudhary S, Ng Y, Saint-Geniez M, et al.
Cell Commun Signal
. 2024 Jun;
22(1):311.
PMID: 38844932
No abstract available.
4.
Cano I, Wild M, Gupta U, Chaudhary S, Ng Y, Saint-Geniez M, et al.
Cell Commun Signal
. 2024 Apr;
22(1):225.
PMID: 38605348
The endothelial glycocalyx, located at the luminal surface of the endothelium, plays an important role in the regulation of leukocyte adhesion, vascular permeability, and vascular homeostasis. Endomucin (EMCN), a component...
5.
Shen J, Rossato F, Cano I, Ng Y
FASEB J
. 2021 Nov;
35(12):e22036.
PMID: 34793603
Therapeutic angiogenesis would be clinically valuable in situations such as peripheral vascular disease in diabetic patients and tissue reperfusion following ischemia or injury, but approaches using traditional isoforms of vascular...
6.
Cano I, Hu Z, AbuSamra D, Saint-Geniez M, Ng Y, Argueso P, et al.
Front Cell Dev Biol
. 2021 Oct;
9:734346.
PMID: 34616740
Galectin-3 (Gal3) is a carbohydrate-binding protein reported to promote angiogenesis by influencing vascular endothelial growth factor-A receptor 2 (VEGFR2) signal transduction. Here we evaluated whether the ability of Gal3 to...
7.
Rossato F, Su Y, Mackey A, Ng Y
Cells
. 2020 Sep;
9(9).
PMID: 32917003
Many patients with wet age-related macular degeneration do not respond well to anti- vascular endothelial growth factor A (VEGFA) therapy for choroidal neovascularization (CNV), and the efficacy of anti-VEGFA decreases...
8.
Shen J, Xiao R, Bair J, Wang F, Vandenberghe L, Dartt D, et al.
Cell Death Dis
. 2018 Oct;
9(10):1018.
PMID: 30282966
Endogenous vascular endothelial growth factor (VEGF-A) can protect retinal ganglion cells (RGC) from stress-induced cell death in ocular hypertensive glaucoma. To exploit the neuroprotective function of VEGF-A for therapeutic application...
9.
Catchpole I, Germaschewski V, Hoh Kam J, Lundh von Leithner P, Ford S, Gough G, et al.
PLoS One
. 2013 Jun;
8(6):e65518.
PMID: 23799019
Age-related macular degeneration (AMD) is a leading cause of legal blindness in the Western world. There are effective treatments for the vascular complications of neo-vascular AMD, but no effective therapies...